Oral Clotrimazole In The Treatment Of Füngal Infection
Part of the
book series (CT, volume 6)
For many years, griseofulvin was the only antifungal anti-biotic which was administered orally. Its usefulness was limited however, by its relative narrow spectrum of activity - effective against the dermatophytes but not against yeasts and systemic mycotic infections. The synthesis of iraidazole derivatives has produced Compounds which have a wide antifungal activity, are effective topically and are absorbed from the gastro intestinal tract.
KeywordsSpontaneous Pneumothorax Left Lower Lobe Vaginal Candidiasis Yeast Infection Lung Damage
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Cartwright, R.Y. Clotrimazole in the treatment of acute and “resistant” vaginal candidiasis. Postgraduate Medical Journal
. (Supplement l) 50; 90–92 (1974)PubMedGoogle Scholar
Cartwright, R.Y., Shaldon, C. and Hall, G.H. Urinary candiasis after renal transplantation. British Medical Journal
. 2; 351 (1972)PubMedCrossRefGoogle Scholar
Crompton, G.K. and Milne, L.J.R. Treatment of bronchopulmonary aspergillosis with clotrimazole. British Journal of Diseases of the Chest
. 67; 301–307 (1973)PubMedCrossRefGoogle Scholar
Tettenborn, D. Toxicity and enzyme inducing activity of clotrimazole. Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakilogie
. 266; 468–469 (1970).CrossRefGoogle Scholar
© Springer Science+Business Media New York 1976